Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Aeterna Zentaris Inc TSX: AEZS-T

Today's Change
Volume
Real-Time Last Update TSX Last Sale

Today's Trading

Day Low 0.61
Day High 0.63
Open:0.62
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company is actively pursuing opportunities to commercialize macimorelin in the EU & the rest of the world.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Globe NewsWire - Wed Sep 8, 7:00AM CDT
Globe NewsWire - PRTGAM
Wed Sep 8, 7:00AM CDT
CHARLESTON, S.C., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and...
Aeterna Zentaris Reports Second Quarter 2021 Financial Results and Provides Pipeline Program Updates
Globe NewsWire - Wed Aug 4, 3:05PM CDT
Globe NewsWire - PRTGAM
Wed Aug 4, 3:05PM CDT
– Company continues to advance clinical and preclinical programs with its d iversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need
Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
Globe NewsWire - Thu Jul 29, 7:05AM CDT
Globe NewsWire - PRTGAM
Thu Jul 29, 7:05AM CDT
CHARLESTON, S.C., July 29, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical...
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.58 +5.17% increase
on 11/24/21
Period Open:0.73
Price movement based on the high, low and last over the given period.
0.84 -27.38% decrease
on 11/04/21
-0.12 (-16.44%) decrease
since 10/29/21
3-Month 0.58 +5.17% increase
on 11/24/21
Period Open:0.92
Price movement based on the high, low and last over the given period.
1.24 -50.81% decrease
on 10/01/21
-0.31 (-33.70%) decrease
since 08/27/21
52-Week 0.42 +45.24% increase
on 12/07/20
Period Open:0.52
Price movement based on the high, low and last over the given period.
4.63 -86.83% decrease
on 02/08/21
+0.09 (+17.31%) increase
since 11/27/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies